Vivos Therapeutics (VVOS) Enterprise Value (2019 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Enterprise Value of -$2.2 million for Q1 2026, up 2.65% year-over-year from -$2.2 million in Q1 2025, and down 7.18% quarter-over-quarter from -$2.1 million in Q4 2025.
Vivos Therapeutics (VVOS) Enterprise Value (2019 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Enterprise Value for 8 consecutive years, with -$2.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Enterprise Value rose 2.65% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at -$2.2 million (up 2.65% YoY), while the FY2025 annual figure was -$2.1 million, up 66.63% from the prior year.
- Enterprise Value declined to -$2.2 million in Q1 2026 per VVOS's latest filing, from -$2.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$988000.0 in Q3 2023 and bottomed at -$17.8 million in Q1 2022.
- Historically, Enterprise Value has averaged -$5.3 million across 5 years, with a median of -$3.9 million in 2023.
- Annual changes were most pronounced in 2022 — Enterprise Value soared 85.34% — and 2024, when it slumped 537.65%.
- Vivos Therapeutics' Enterprise Value stood at -$3.5 million in 2022, then surged by 53.31% to -$1.6 million in 2023, then slumped by 281.01% to -$6.3 million in 2024, then surged by 66.63% to -$2.1 million in 2025, then fell by 7.18% to -$2.2 million in 2026.
- Business Quant data shows VVOS's Enterprise Value at -$2.2 million in Q1 2026, -$2.1 million in Q4 2025, and -$3.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -4.95 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -297.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -4.15 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -1.88 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -3.29 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -467.80 Mn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | -1.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.24 Mn |
| Dec 31, 2025 | -2.09 Mn |
| Sep 30, 2025 | -3.10 Mn |
| Jun 30, 2025 | -4.40 Mn |
| Mar 31, 2025 | -2.30 Mn |
| Dec 31, 2024 | -6.26 Mn |
| Sep 30, 2024 | -6.30 Mn |
| Jun 30, 2024 | -6.90 Mn |
| Mar 31, 2024 | -2.60 Mn |
| Dec 31, 2023 | -1.64 Mn |
| Sep 30, 2023 | -988,000.00 |
| Jun 30, 2023 | -3.90 Mn |
| Mar 31, 2023 | -7.00 Mn |
| Dec 31, 2022 | -3.52 Mn |
| Sep 30, 2022 | -6.72 Mn |
| Jun 30, 2022 | -12.66 Mn |
| Mar 31, 2022 | -17.83 Mn |
| Dec 31, 2021 | -24.00 Mn |
| Sep 30, 2021 | -28.50 Mn |
| Jun 30, 2021 | -34.20 Mn |